Skip to main content Skip to main menu

PRIORITIZE

A pragmatic, randomized study of oral regimens for hepatitis C

Study Management

Partners In Research

This study is supported through a Patient-Centered Outcomes Research Institute (PCORI) Award with additional support from the following partners:

  • AbbVie
  • Merck Sharpe & Dohme Corp.
  • Monogram Biosciences
  • TLC Rx Pharmacy